These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21708084)

  • 21. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
    Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
    J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.
    Quivey JM; Augsburger J; Snelling L; Brady LW
    Cancer; 1996 Jun; 77(11):2356-62. PubMed ID: 8635107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE MACULA AFTER PLAQUE RADIOTHERAPY OF CHOROIDAL MELANOMA: Comparison of Irradiated Versus Nonirradiated Eyes in 65 Patients.
    Shields CL; Say EA; Samara WA; Khoo CT; Mashayekhi A; Shields JA
    Retina; 2016 Aug; 36(8):1493-505. PubMed ID: 26960015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients.
    Shields CL; Shields JA; Cater J; Gündüz K; Miyamoto C; Micaily B; Brady LW
    Arch Ophthalmol; 2000 Sep; 118(9):1219-28. PubMed ID: 10980767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study.
    Kaliki S; Shields CL; Rojanaporn D; Badal J; Devisetty L; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2013 May; 120(5):1004-11. PubMed ID: 23347983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of ciliary body melanoma with iodine-125 plaque brachytherapy.
    Krema H; Simpson ER; Pavlin CJ; Payne D; Vasquez LM; McGowan H
    Can J Ophthalmol; 2009 Aug; 44(4):395-400. PubMed ID: 19606159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
    Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL
    Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age.
    Chang M; Dalvin LA; Mazloumi M; Martin A; Yaghy A; Yang X; Bakhtiari S; Li L; Jennings E; Mashayekhi A; Shields CL
    Asia Pac J Ophthalmol (Phila); 2020; 9(1):29-38. PubMed ID: 31990743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: a mono-institutional experience.
    Perri P; Fiorica F; D'Angelo S; Lamberti G; Parmeggiani F; Martini A; Carpenteri F; Colosimo C; Micucci M; Perazzini L; De Gugliemo E; Berretta M; Sebastiani A; Cartei F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1919-24. PubMed ID: 23242717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
    Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
    Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.
    Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
    Br J Ophthalmol; 1996 Aug; 80(8):732-9. PubMed ID: 8949719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma.
    Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; O'Regan M; Shields JA
    Retina; 2008; 28(7):987-95. PubMed ID: 18698302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.
    Caminal JM; Flores-Moreno I; Arias L; Gutiérrez C; Piulats JM; Català J; Rubio MJ; Cobos E; García P; Pera J; Giralt J; Arruga J
    Retina; 2015 Sep; 35(9):1890-7. PubMed ID: 26035401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tyndallometry for follow-up of iodine-125 brachytherapy of uveal malignant melanomas. Report of 2 patients].
    Nguyen NX; Küchle M; Strunk W
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):25-30. PubMed ID: 8965473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-related lipid exudation and associated tumor-related complications after plaque radiotherapy of posterior uveal melanoma.
    Mashayekhi A; Tuncer S; Shields CL; Shields JA
    Eur J Ophthalmol; 2013; 23(3):399-409. PubMed ID: 23483500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plaque radiotherapy for the management of uveal metastasis.
    Shields CL; Shields JA; De Potter P; Quaranta M; Freire J; Brady LW; Barrett J
    Arch Ophthalmol; 1997 Feb; 115(2):203-9. PubMed ID: 9046255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retina dose as a predictor for visual acuity loss in
    Heilemann G; Fetty L; Blaickner M; Nesvacil N; Zehetmayer M; Georg D; Dunavoelgyi R
    Radiother Oncol; 2018 Jun; 127(3):379-384. PubMed ID: 29452902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iodine 125 brachytherapy with vitrectomy and silicone oil in the treatment of uveal melanoma: 1-to-1 matched case-control series.
    McCannel TA; McCannel CA
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):347-52. PubMed ID: 24721588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective Analysis of Radiation-Induced Complications of Uveal Melanoma Patients Treated With Brachytherapy in the Era of Anti-VEGF.
    Hasegawa N; Teh BS; Tran K; Ivey F; Olek D; Pino R; Chuang AZ; Bretana ME; Butler EB; Schefler AC
    Am J Ophthalmol; 2024 Apr; 260():49-59. PubMed ID: 38081570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.